| Primary information |
|---|
| ID | 20654 |
| Pubchem ID | 25077649 |
| Name | Nafarelin |
| Description | Nafarelin is only found in individuals that have used or taken this drug. It is a potent synthetic agonist of gonadotropin-releasing hormone with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the treatments of central precocious puberty and endometriosis. [PubChem]Li |
| Synonym | Nafarelin acetate;Nafarelin acetate; hydrate;Synarel;Nafarelin monoacetate;Nafarelin acetate;Nafarelin acetate; hydrate;Synarel;Nafarelin monoacetate;Nafarelin acetate; hydrate;Synarel;Nafarelin monoa |
| Molecular Weight | 1322.4713 |
| Formula | C66H83N17O13 |
| IUPAC | N-(5-carbamimidamido-1-{2-[(carbamoylmethyl)carbamoyl]pyrrolidin-1-yl}-1-oxopentan-2-yl)-2-{2-[2-(3-hydroxy-2-{2-[3-(1H-imidazol-4-yl)-2-[(5-oxopyrrolidin-2-yl)formamido]propanamido]-3-(1H-indol-3-yl)propanamido}propanamido)-3-(4-hydroxyphenyl)propanamido]-3-(naphthalen-2-yl)propanamido}-4-methylpentanamide |
| SMILE | CC(C)CC(NC(=O)C(CC1=CC2=CC=CC=C2C=C1)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CO)NC(=O)C(CC1=CNC2=CC=CC=C12)NC(=O)C(CC1=CNC=N1)NC(=O)C1CCC(=O)N1)C(=O)NC(CCCNC(N)=N)C(=O)N1CCCC1C(=O)NCC(N)=O |
| PDB ID | NA |
| KEGG | C07613 |
| HMDB ID | HMDB0014804 |
| Melting Point (Degree C) | NA |
| Water Solubility | 0.017 g/L |
| Drugbank ID | NA |
| Receptor | NA |
| Reference | HMDB
|